Chimeric antigen receptor T-cell (CAR T-cell) therapy is a process developed to treat certain forms of cancers, especially blood cancers like leukemia and lymphoma. Recently, however, researchers have started exploring…
Continue Reading
Last call for comments for DM PFDD
TMA was honored to partner with Myositis Support and Understanding (MSU) to host the Externally Led Patient Focused Drug Development (PFDD) meeting for adult dermatomyositis (DM) on June 7. View…
Continue Reading
TMA’s top 10 travel tips
TMA’s top 10 travel tips help you achieve those bucket-list wishes, including making the most of our International Annual Patient Conference.
Continue Reading
Dermatomyositis: A many-headed monster
The first-ever Externally Led Patient Focused Drug Development (EL-PFDD) meeting on June 7 offered a critical way for patients and their family members to highlight what life with DM is like.
Continue Reading
Raising the voice of patients in research
TMA medical advisor and patient advocate Ingrid de Groot insists patients be involved in medical research.
Continue Reading